SCHEMBL251729

SCHEMBL251729

O=C(O)NCc1ccc(C2CCC3(CC2)OCCO3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
MAPK1 P28482 1/20 0.41
JAK3 P52333 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
IKBKE Q14164 1/20 0.39
TBK1 Q9UHD2 1/20 0.39
MAPT P10636 3/20 0.38
HPGD P15428 2/20 0.38
RAB9A P51151 2/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL252733 0.82 NAMPT (0.45) ALDH1A1L3MBTL1HTR2CHTR2BMAPT
SCHEMBL10131989 0.79 IKBKE (0.38) ALDH1A1IKBKETBK1C5AR1
SCHEMBL1780897 0.78 ESR2 (0.44) ALDH1A1L3MBTL1IKBKETBK1CYP2C9
SCHEMBL14403053 0.77 ESR2 (0.42) IKBKETBK1KDM4E
SCHEMBL744889 0.77 IKBKE (0.45) ALDH1A1IKBKETBK1HPGDTSHR
SCHEMBL9269519 0.76 ALDH1A1 (0.44) ALDH1A1L3MBTL1MAPK1IKBKETBK1
SCHEMBL615968 0.75 LIPE (0.41) ALDH1A1SMN1; SMN2MAPTC5AR1LMNA
SCHEMBL6677219 0.75 ESR2 (0.37) IKBKETBK1C5AR1
SCHEMBL15121581 0.74 C5AR1 (0.39) ALDH1A1L3MBTL1IKBKETBK1HTT
SCHEMBL3546414 0.74 IKBKE (0.41) ALDH1A1L3MBTL1MAPK1SMN1; SMN2IKBKE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401275-B1 NAPHTHYRIDINE DERIVATIVES HAVING BRONCHODILATING ACTIVITY RESPIRATORIUS AB (SE) 2013-07-24 EP disclosed
US-8415333-B2 Bronchodilating diazaheteroaryls RESPIRATORIOUS AB (SE) 2013-04-09 US disclosed
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2012-02-16 US disclosed
EP-2401275-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS Respiratorius AB (SE) 2012-01-04 EP disclosed
WO-2010097410-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS RESPIRATORIUS AB (SE) 2010-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040942-A1 NOVEL BRONCHODILATING DIAZAHETEROARYLS CHRM3, ADRB1, ADRB3 ALDH1A1 468/4885L3MBTL1 3730/4885HTR2C 2158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.